Target intelligence / Profile preview

Venous endothelial cell membrane

Molecular classification
Other
01

Overview

The venous endothelial cell membrane is the thin, semi-permeable barrier lining the interior of veins, playing a critical role in vascular homeostasis, blood fluidity, and the regulation of inflammatory responses (Beckman Coulter, 2025; PMC, 2021). In clinical practice, it serves as the primary therapeutic target for sclerotherapy, where agents like polidocanol or sodium tetradecyl sulfate are used to induce controlled endothelial damage (StatPearls, 2024; PubMed, 2000). This damage triggers a cascade of protein denaturation, cell lysis, and localized thrombosis, ultimately leading to the fibrotic occlusion and disappearance of diseased vessels such as varicose veins (Plastic Surgery Key, 2016; PMC, 2011). Beyond its role in mechanical obliteration, the membrane expresses various surface markers like ICAM-1 and PECAM-1, which are increasingly targeted by nanomedicines for site-specific drug delivery in inflammatory and cardiovascular diseases (PMC, 2020; PMC, 2009). However, therapeutic manipulation of this target carries risks, including unintended deep vein thrombosis or localized tissue necrosis if the agents affect non-target areas (StatPearls, 2024; MDPI, 2024). The membrane also acts as a dynamic sensor of shear stress and biochemical signals, modulating vascular tone through the release of factors like nitric oxide and prostacyclin (PMC, 2021; Dr.Oracle, 2025). Dysfunction or disruption of this membrane is a hallmark of various venous pathologies, making its preservation or targeted destruction a key clinical objective (MDPI, 2024; Circulation, 2021).

Other names
Vascular endothelium (venous)Venous intimal liningVenous endothelial surfaceEndothelial plasma membrane
02

Mechanism of action

Sclerosing agents interact with the venous endothelial cell membrane through various mechanisms: detergent sclerosants cause protein denaturation and lipid bilayer disruption; osmotic agents induce cellular dehydration; and chemical irritants cause direct caustic destruction. These actions lead to endothelial cell death, localized thrombus formation, and subsequent endofibrosis, resulting in the permanent occlusion of the targeted vein.

03

Biological functions

Barrier functionHemostasisSignal transductionImmune responseCell adhesion
04

Disease associations

Cardiovascular diseaseInflammationOther
05

Safety considerations

Deep vein thrombosis (DVT)Pulmonary embolism (PE)Skin necrosisHyperpigmentationAnaphylaxisVisual disturbances
06

Interacting drugs

Polidocanol

5 more in the full profile.

07

Biomarkers

D-dimerEndothelial microparticles (EMPs)Soluble ICAM-1 (sICAM-1)Soluble VCAM-1 (sVCAM-1)

Beyond the preview

Go deeper on Venous endothelial cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venous endothelial cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call